Method: We conducted a retrospective review of all patients who underwent a parotidectomy with either AlloDerm or autologous FDFG reconstruction by a single surgeon since January 1997. Complications were identified and patients from both cohorts were contacted by telephone to assess cosmetic satisfaction using a novel analogue scale.
Results: Sixty-five patients who received AlloDerm reconstruction and 35 patients who received FDFG reconstruction were analyzed. The incidence of complications following FDFG was 3% (n = 1) compared with 5% (n = 3) after AlloDerm implantation (P = 1.000). Both cohorts rated their recon struction on symmetry (1-worst to 5-best), degree of change (1-least to 5-most), and overall satisfaction (1-worst to 5-best). Patients with FDFG reconstruction reported favorable cosmesis with respect to symmetry (4.5 ± 0.7) and overall appearance (4.8 ± 0.4), while indicating mild changes in their appearance over time (2.0 ± 1.2). At the time of this writing, cosmetic assessment of AlloDerm patients was underway but incomplete.
Conclusion: FDFG and AlloDerm are cosmetically and functionally viable options to reconstruct the post-ablative parotid bed. Both modalities demonstrated similarly low complication rates (P = 1.000), and an assessment of long-term patient satisfaction with AlloDerm will determine how it compares to the cosmetically efficacious FDFG.
Head and Neck Surgery Methylome Analysis of HPV-Associated Head and Neck Cancer
Matthias Alexander Lechner, MRCS, DLO (presenter); Andrew Feber; Andrew Teschendorff; Chris Boshoff; Gareth Wilson; Lee M. Butcher;
Stephan Beck
Objective: A significant proportion of HNSCC is caused by human papillomavirus. Patients diagnosed with this subtype have a significantly better outcome. It is the aim of the UCL Head and Neck Cancer Epigenome Project to generate and analyze comprehensive, genome-wide profiles of epigenetic aberrations in this specific type of human cancer.
Method: Whole-genome DNA methylation (methylome) analysis of 3 HPV positive and 3 HPV negative frozen HNSCC samples (obtained from the UCL Head and Neck Cancer Tissue Bank as part of a larger discovery set) was conducted using methylated DNA immunoprecipitation coupled with next-generation sequencing (MeDIP-Seq).
Results: On average, each sample in the pilot phase generated 2 x 10 7 sequencing reads and 70% coverage of all CpG sites within the host genome. HPV type 16 was observed in all HPV positive samples and, interestingly, methylated regions of this virus were identified-most notably at genes E1 and L1 (previously shown to have been methylated in cervical cancer). We also detected multiple methylation changes between HPV positive and HPV negative host's methylomes, of which a significant proportion mapped to genes previously shown to display down-regulated expression in transcriptionally active HPV positive oropharyngeal cancer.
Conclusion:
The observed epigenetic differences between the 2 types might explain the different clinical behavior of HPVassociated HNSCC. Although preliminary, these pilot data are encouraging with respect to the possibility of identifying potential diagnostic and prognostic markers, as well as putative therapeutic targets in this subtype of HNSCC.
Head and Neck Surgery Molecular Identification of Human Papillomavirus DNA in Thyroid Neoplasms
Maria Ivette Mucino Hernandez, MD (presenter); Alejandro Gonzalez Ojeda; Alfonso Bencomo Alvarea; Elias Morales Jeahns; Jose Gonzalo Vazquez Camacho; Luz Margarita Baltazar Rodriguez; Hector Montoya Fuentes, PhD
Objective: Estimate the HPV frequency and types in neoplastic thyroid tissue by means of Polymerase Chain Reaction-Restriction Fragments Length Polymorphisms (PCR-RFLP).
Method: Transversal study. We analyzed 157 samples from malignant and benign thyroid tumors of paraffin-embedded tissue. All the paraffin blocks were randomly chosen from the archive of Pathology Tissue Bank (Centro Medico Nacional de Occidente, IMSS). The molecular detection and typing was performed at Molecular Microbiology II Laboratory in CIBO.
Results:
The HPV observed frequency was 2.5% (4 cases). HPV-6 was found in 2 cases of thyroid hyperplasia (2.5%) and HPV-33 in 2 cases of Papillary Cancer (4.6%).
Conclusion: HPV is not frequent in thyroid neoplasms, at least in the studied population. The HPV types found were HPV-6 in hyperplasia and HPV-33 in papillary cancer.
Head and Neck Surgery Neuroendocrine Neoplasms of the Larynx: Outcomes of 15 Cases
Paulo Mello (presenter); Jacob Klingerman; Pedro Milet; Jose Soares, MD; Ullyanov B. Toscano, MD; Fernando Luiz Dias, MD, PhD; Roberto Lima, MD, PhD
Objective: Neuroendocrine neoplasms of the larynx (NNL), although rare, are the most common nonsquamous tumors of this organ. The aim of the study is to evaluate the presentation, treatment, and outcome of a consecutive series of 15 patients with NNL of the larynx and to provide information for therapeutic decision making.
Method: Retrospective analysis of medical records. Cases were identified from databases maintained by the medical informatics and pathology departments. Main outcome measures were recurrence, overall survival, and disease-specific survival (OS and DSS).
